The implications of suboptimal year-1 outcomes with disease-modifying therapy in employees with multiple sclerosis Apr 5, 2021
Trends in Absence Time and Payments Due to Long- and Short-Term Disability and Workers’ Compensation for Employees with Multiple Sclerosis in the United States Apr 5, 2021
Assessing Presence of MS-Related Symptoms as a Proxy for Disease Severity in Multiple Sclerosis Using Administrative Claims Data Mar 26, 2021
Healthcare Costs and Absenteeism Among Caregivers of Adults with Partial-Onset Seizures: Analysis of Claims from an Employer Database Jul 7, 2020
The Implications of Suboptimal Treatment Outcomes with Disease-Modifying Drugs in Employees with Multiple Sclerosis Jul 7, 2020
